161 related articles for article (PubMed ID: 37541149)
1. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry.
Koga M; Izumo M; Yoneyama K; Akashi YJ; Yashima F; Tada N; Yamawaki M; Shirai S; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
Am J Cardiol; 2023 Oct; 204():130-139. PubMed ID: 37541149
[TBL] [Abstract][Full Text] [Related]
2. Regression of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Tobe A; Tanaka A; Tokuda Y; Akita S; Fujii T; Miki Y; Furusawa K; Ishii H; Usui A; Murohara T
Circ J; 2021 Jun; 85(7):1093-1098. PubMed ID: 34039838
[TBL] [Abstract][Full Text] [Related]
3. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement.
Yang Y; Ahn JM; Kang DY; Ko E; Kim S; Kim TO; Kim JH; Lee J; Lee SA; Kim DH; Kim HJ; Kim JB; Choo SJ; Park SJ; Park DW
J Am Heart Assoc; 2022 Feb; 11(4):e023647. PubMed ID: 35112886
[TBL] [Abstract][Full Text] [Related]
4. Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.
Kampaktsis PN; Ullal AV; Swaminathan RV; Minutello RM; Kim L; Bergman GS; Feldman DN; Singh H; Wong SC; Okin PM
Clin Cardiol; 2018 Sep; 41(9):1246-1251. PubMed ID: 30062778
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
[TBL] [Abstract][Full Text] [Related]
6. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of electrocardiographic left ventricular hypertrophy following transcatheter aortic valve replacement.
Tanaka T; Yahagi K; Asami M; Ninomiya K; Kikushima H; Okuno T; Horiuchi Y; Yuzawa H; Komiyama K; Tanaka J; Yokozuka M; Miura S; Aoki J; Tanabe K
J Cardiol; 2021 Apr; 77(4):346-352. PubMed ID: 33455846
[TBL] [Abstract][Full Text] [Related]
8. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
Sjöberg S; Sundh F; Schlegel T; Maynard C; Rück A; Wagner G; Ugander M
J Electrocardiol; 2015; 48(4):630-6. PubMed ID: 25865909
[TBL] [Abstract][Full Text] [Related]
9. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
[TBL] [Abstract][Full Text] [Related]
11. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
[TBL] [Abstract][Full Text] [Related]
12. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
13. Effect of Sex on Mortality and Left Ventricular Remodeling After Transcatheter Aortic Valve Implantation.
Shishido K; Yamanaka F; Ochiai T; Moriyama N; Yokoyama H; Yokota S; Noguchi K; Yashima F; Tada N; Naganuma T; Araki M; Shirai S; Ueno H; Mizutani K; Tabata M; Takagi K; Watanabe Y; Yamamoto M; Saito S; Hayashida K
Circ J; 2021 Jun; 85(7):979-988. PubMed ID: 33907051
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement.
Ito N; Zen K; Takahara M; Tani R; Nakamura S; Fujimoto T; Takamatsu K; Yashige M; Kadoya Y; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
ESC Heart Fail; 2023 Apr; 10(2):1336-1346. PubMed ID: 36725669
[TBL] [Abstract][Full Text] [Related]
15. Absence of electrocardiographic left ventricular hypertrophy and poor outcome in patients undergoing transcatheter aortic valve replacement-A systematic review and meta-analysis.
Martha JW; Pranata R; Yonas E; Wibowo A; Akbar MR
J Card Surg; 2021 Jul; 36(7):2233-2239. PubMed ID: 33768590
[TBL] [Abstract][Full Text] [Related]
16. Absence of electrocardiographic left ventricular hypertrophy in patients undergoing Transcatheter aortic valve replacement is associated with increased mortality.
Zhang R; Jou S; Cao Y; Keller K; Xiao E; de La Rosa A; DeLago A; El-Hajjar M; Torosoff M
J Electrocardiol; 2020; 63():12-16. PubMed ID: 33017756
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
[TBL] [Abstract][Full Text] [Related]
18. Effect of Serum C-Reactive Protein Level on Admission to Predict Mortality After Transcatheter Aortic Valve Implantation.
Hioki H; Watanabe Y; Kozuma K; Yamamoto M; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Higashimori A; Mizutani K; Tabata M; Takagi K; Ueno H; Hayashida K;
Am J Cardiol; 2018 Jul; 122(2):294-301. PubMed ID: 29735216
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
Pedersen ALD; Povlsen JA; Rasmussen VG; Frederiksen CA; Christiansen EH; Terkelsen CJ; Vase H; Poulsen SH
Int J Cardiovasc Imaging; 2023 Jan; 39(1):13-22. PubMed ID: 36598683
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.
Spaziano M; Chieffo A; Watanabe Y; Chandrasekhar J; Sartori S; Lefèvre T; Petronio AS; Presbitero P; Tchetche D; Iadanza A; Van Mieghem NM; Mehilli J; Mehran R; Morice MC;
J Cardiovasc Comput Tomogr; 2018; 12(4):338-343. PubMed ID: 29735255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
